Literature DB >> 17591018

Complementary and alternative medicine (CAM) for the treatment of chronic hepatitis B and C: a review.

Apurva A Modi1, Elizabeth C Wright, Leonard B Seeff.   

Abstract

Complementary and alternative medicine (CAM) has been used for centuries in China and Japan to treat various illnesses, including viral hepatitis. Several therapeutic approaches constitute CAM, the most relevant for this review being the use of herbals. However, profound disagreements exist between conventional and alternative medicine practitioners regarding their value. Western medical advocates cite deep concerns about the purity of most herbals because of lack of standardized production, the paucity of pharmacokinetic data, the fact that few well-designed randomized, controlled trials of these products have been performed and the evidence that some herbals have been responsible for severe adverse effects. Nevertheless, many in the public, even in western countries, turn to the use of herbals, believing that they must be safe and effective because they are 'natural' and have been used for centuries, and because of dissatisfaction with conventional medicine. Accordingly, their use in western countries and the costs incurred have increased each year. While there is evidence that some herbals have physiological effects, there still is insufficient evidence to recommend their use. This paper reviews the classification, epidemiology and philosophy of CAM, and the reasons advanced for herbal use to treat viral hepatitis. The criteria necessary to develop a potential pharmacological agent are presented, as well as the requirements for conducting a scientifically valid treatment trial of herbals. Five herbals used in the past to treat viral hepatitis are reviewed and evaluated for the quality of their studies and mention is made of herbals known to have adverse effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17591018

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  8 in total

Review 1.  Protease inhibitors for hepatitis C: economic implications.

Authors:  Stuart J Turner; Jack Brown; Joseph A Paladino
Journal:  Pharmacoeconomics       Date:  2013-09       Impact factor: 4.981

Review 2.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

3.  Complementary and alternative medicines for hepatic disease.

Authors:  Leonard B Seeff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-01

Review 4.  Management of untreated and nonresponder patients with chronic hepatitis C.

Authors:  Leonard B Seeff; Marc G Ghany
Journal:  Semin Liver Dis       Date:  2010-10-19       Impact factor: 6.115

5.  Efficacy and safety of Chlorella supplementation in adults with chronic hepatitis C virus infection.

Authors:  Jose Azocar; Arley Diaz
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

6.  Risk of liver injury associated with Chinese herbal products containing radix bupleuri in 639,779 patients with hepatitis B virus infection.

Authors:  Chang-Hsing Lee; Jung-Der Wang; Pau-Chung Chen
Journal:  PLoS One       Date:  2011-01-12       Impact factor: 3.240

7.  Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B.

Authors:  De Zhao Kong; Ning Liang; Guan Lin Yang; Zhe Zhang; Yue Liu; Jing Li; Xuehan Liu; Shibing Liang; Dimitrinka Nikolova; Janus C Jakobsen; Christian Gluud; Jian Ping Liu
Journal:  Cochrane Database Syst Rev       Date:  2019-11-07

8.  Utilization and prescription patterns of traditional Chinese medicine for patients with hepatitis C in Taiwan: a population-based study.

Authors:  Chia-Yu Liu; Jui-Ying Chu; Jen-Huai Chiang; Hung-Rong Yen; Chung-Hua Hsu
Journal:  BMC Complement Altern Med       Date:  2016-10-21       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.